1. Home
  2. GLMD vs GBR Comparison

GLMD vs GBR Comparison

Compare GLMD & GBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLMD
  • GBR
  • Stock Information
  • Founded
  • GLMD 2000
  • GBR 1978
  • Country
  • GLMD Israel
  • GBR United States
  • Employees
  • GLMD N/A
  • GBR N/A
  • Industry
  • GLMD Biotechnology: Pharmaceutical Preparations
  • GBR Oil & Gas Production
  • Sector
  • GLMD Health Care
  • GBR Energy
  • Exchange
  • GLMD Nasdaq
  • GBR Nasdaq
  • Market Cap
  • GLMD 5.9M
  • GBR 6.1M
  • IPO Year
  • GLMD 2014
  • GBR N/A
  • Fundamental
  • Price
  • GLMD $2.80
  • GBR $1.19
  • Analyst Decision
  • GLMD
  • GBR
  • Analyst Count
  • GLMD 0
  • GBR 0
  • Target Price
  • GLMD N/A
  • GBR N/A
  • AVG Volume (30 Days)
  • GLMD 66.9K
  • GBR 15.8K
  • Earning Date
  • GLMD 11-29-2024
  • GBR 11-13-2024
  • Dividend Yield
  • GLMD N/A
  • GBR N/A
  • EPS Growth
  • GLMD N/A
  • GBR N/A
  • EPS
  • GLMD N/A
  • GBR N/A
  • Revenue
  • GLMD N/A
  • GBR $147,000.00
  • Revenue This Year
  • GLMD N/A
  • GBR N/A
  • Revenue Next Year
  • GLMD N/A
  • GBR N/A
  • P/E Ratio
  • GLMD N/A
  • GBR N/A
  • Revenue Growth
  • GLMD N/A
  • GBR N/A
  • 52 Week Low
  • GLMD $2.73
  • GBR $0.95
  • 52 Week High
  • GLMD $23.80
  • GBR $1.82
  • Technical
  • Relative Strength Index (RSI)
  • GLMD 37.59
  • GBR 49.40
  • Support Level
  • GLMD $2.84
  • GBR $1.16
  • Resistance Level
  • GLMD $3.05
  • GBR $1.21
  • Average True Range (ATR)
  • GLMD 0.24
  • GBR 0.05
  • MACD
  • GLMD 0.04
  • GBR 0.00
  • Stochastic Oscillator
  • GLMD 8.33
  • GBR 50.00

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.

About GBR New Concept Energy Inc

New Concept Energy Inc is a United States-based company engaged in Real Estate Operations. It intends to continue to operate and or sell its West Virginia property. It provides advisory and management services for an independent West Virginia oil and gas company. The Company seeks to establish or acquire new business operations. It operates in one segment, which is real estate rental.

Share on Social Networks: